Formulation: Advances in formulation development & manufacture for solid dosage, injectables, liquids & specialty dosage forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Formulation
Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

Prefilled Syringes or Peptide Pills?

May 2, 2013

Pharmaceutical Technology

The impact of new delivery technologies in designing peptide therapies.

Fine-Chemical Producers Make Targeted Investments

April 2, 2013

Pharmaceutical Technology

Contract API manufacturers proceed with select investment in capacity and service additions.

Measuring API Particle Size Distribution

March 2, 2013

Pharmaceutical Technology

Visual mapping can provide a particle-size distribution estimate.

Nanoparticles:Facilitating Targeted Drug Delivery in Cancer Therapy

March 2, 2013

Pharmaceutical Technology

Engineering nanoparticles with optimal properties for use in cancer therapies.

Advancing Polymers for Solubility Enhancement

March 1, 2013

Pharmaceutical Technology

Pharmaceutical Technology brought together a panel of industry experts for a special forum to discuss solubilizing polymers and the related formulation strategies for poorly soluble drugs.

Tackling Common Problems in Tableting and Tooling

March 1, 2013

Pharmaceutical Technology

The tableting science anti-research (TSAR) project seeks to understand why certain formulations stick to tablet tooling.

The Ph.Eur. approach to tablet splitting

March 1, 2013
Pharmaceutical Technology

An alternative chapter has been added to the European Pharmacopoeia for dosage uniformity.

Concerns and Innovations in Tablet Splitting and Scoring

March 1, 2013
Pharmaceutical Technology

A roundtable discussion of the challenges and innovations in tablet splitting featuring Freeman Technology, Accu-Break Pharmaceuticals, and Medelpharm.

Development and Commercialization of a Novel Modified Release Tablet Technology

December 2, 2012

Pharmaceutical Technology

GlaxoSmithKline recently developed a novel technology for the formulation of modified-release tablets. The authors describe the route from development to commercialization.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here